Corvium (formerly Sample6) is a synthetic, biology-based bacteria diagnostic system that is capable of enrichment-free detection. The Company provides organizations in the food industry with access to real-time factual information regarding the changing risk status of their operations. Its Control workflow enables continuous visualization, monitoring, analytics, and up-to-date documentation of food safety testing across multiple production facilities.
|Employees (est.) (Nov 2019)||30||(+4%)|
Corvium total Funding
Corvium latest funding size
Time since last funding
|3 years ago|
|Flybridge Capital Partners, Canaan Partners, Founder Collective, Cultivian Sandbox Ventures, Tim Lu, Valley Oak Investments, Acre Venture Partners|
Corvium has 972 Twitter Followers. The number of followers has increased 0.2% month over month and decreased 0.2% quarter over quarter
When was Corvium founded?
Corvium was founded in 2009.
Who are Corvium key executives?
Corvium's key executives are Tim Curran, Michael Koeris and Daniel Brownell.
How many employees does Corvium have?
Corvium has 30 employees.
Who are Corvium competitors?
Competitors of Corvium include Translate Bio, WuXi NextCODE and HiberGene Diagnostics.
Where is Corvium headquarters?
Corvium headquarters is located at 12100 Sunset Hills Rd #100, Reston.
Where are Corvium offices?
Corvium has offices in Reston and Boston.
How many offices does Corvium have?
Corvium has 2 offices.
Receive alerts for 300+ data fields across thousands of companies